Director

Todd Davis

Todd Davis is Chief Executive Officer of Ligand and has served on the company’s Board of Directors since 2007. He has more than 30 years of operational and investment experience and has been involved in more than $4 billion in healthcare financings over his career.

Before joining Ligand, Mr. Davis was a Founder and Managing Partner of HealthCare Royalty Partners, a global healthcare investment firm which grew from zero to approximately $4 billion in capital commitments during his tenure. He previously served as a partner responsible for biopharmaceutical growth equity investments at Apax Partners. Mr. Davis began his career in sales at Abbott Laboratories and later held leadership roles at Elan Pharmaceuticals in corporate development and general management.

Mr. Davis is a Navy combat veteran and holds a BS from the U.S. Naval Academy and an MBA from Harvard Business School. He currently serves on the boards of Palvella Therapeutics Inc. (Nasdaq: PVLA) and ViroCell Biologics. He is a former board member of the Harvard Business School Healthcare Alumni Association.